CEL-SCI CORPORATION Increase (Decrease) in Intangible Assets, Current
CEL-SCI CORPORATION (CVM) reported Increase (Decrease) in Intangible Assets, Current of $0 for the 9-month period ending 2015-06-30, per its 10-Q filed 2015-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent · last filed 2015-08-07
- CEL-SCI CORPORATION increase (decrease) in intangible assets, current for the quarter ending 2014-09-30 was -$5.53K, a 728.56% decline year-over-year.
- CEL-SCI CORPORATION increase (decrease) in intangible assets, current for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- CEL-SCI CORPORATION increase (decrease) in intangible assets, current for the quarter ending 2014-03-31 was $791.00, a 36.67% decline year-over-year.
- CEL-SCI CORPORATION increase (decrease) in intangible assets, current for the quarter ending 2013-12-31 was $9.21K, a 6.56% increase year-over-year.
- CEL-SCI CORPORATION increase (decrease) in intangible assets, current for fiscal 2014 was $4.47K, a 68.10% decline from fiscal 2013.
- CEL-SCI CORPORATION increase (decrease) in intangible assets, current for fiscal 2013 was $14.02K, a 37.33% decline from fiscal 2012.
- CEL-SCI CORPORATION increase (decrease) in intangible assets, current for fiscal 2012 was $22.38K, a 21.56% decline from fiscal 2011.
- CEL-SCI CORPORATION increase (decrease) in intangible assets, current for fiscal 2011 was $28.53K.
| Period end | Increase (Decrease) in Intangible Assets, Current 3 month | Increase (Decrease) in Intangible Assets, Current 6 month | Increase (Decrease) in Intangible Assets, Current 6 month as first filed | Increase (Decrease) in Intangible Assets, Current 9 month | Increase (Decrease) in Intangible Assets, Current 9 month as first filed | Increase (Decrease) in Intangible Assets, Current 12 month |
|---|---|---|---|---|---|---|
| 2015-06-30 | $0.00 10-Q · filed 2015-08-07 | |||||
| 2014-09-30 | -$5.53K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-23 | -$5.53K derived: sum of 2 quarters · filed 2015-08-07 | -$4.73K derived: sum of 3 quarters · filed 2015-08-07 | $4.47K 10-K · filed 2014-12-23 | ||
| 2014-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-07 | $791.00 derived: sum of 2 quarters · filed 2015-08-07 | $10.00K 10-Q · filed 2015-08-07 | $6.10K 10-Q · filed 2014-08-08 | $10.88K derived: sum of 4 quarters · filed 2015-08-07 | |
| 2014-03-31 | $791.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | $10.00K 10-Q · filed 2015-05-08 | -$14.02K 10-Q · filed 2014-05-12 | $10.88K derived: sum of 3 quarters · filed 2015-05-08 | $14.13K derived: sum of 4 quarters · filed 2015-05-08 | |
| 2013-12-31 | $9.21K 10-Q · filed 2014-02-10 | $10.09K derived: sum of 2 quarters · filed 2014-12-23 | $13.34K derived: sum of 3 quarters · filed 2014-12-23 | $14.59K derived: sum of 4 quarters · filed 2014-12-23 | ||
| 2013-09-30 | $879.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-23 | $4.13K derived: sum of 2 quarters · filed 2014-12-23 | $5.38K derived: sum of 3 quarters · filed 2014-12-23 | $14.02K 10-K · filed 2014-12-23 | ||
| 2013-06-30 | $3.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-08 | $4.50K derived: sum of 2 quarters · filed 2014-08-08 | $13.14K 10-Q · filed 2014-08-08 | $35.52K derived: sum of 4 quarters · filed 2014-12-23 | ||
| 2013-03-31 | $1.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | $9.89K 10-Q · filed 2014-05-12 | $32.27K derived: sum of 3 quarters · filed 2014-12-23 | $32.27K derived: sum of 4 quarters · filed 2014-12-23 | ||
| 2012-12-31 | $8.64K 10-Q · filed 2014-02-10 | $31.02K derived: sum of 2 quarters · filed 2014-12-23 | $31.02K derived: sum of 3 quarters · filed 2014-12-23 | $15.74K derived: sum of 4 quarters · filed 2014-12-23 | ||
| 2012-09-30 | $22.38K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-23 | $22.38K derived: sum of 2 quarters · filed 2014-12-23 | $7.10K derived: sum of 3 quarters · filed 2014-12-23 | $22.38K 10-K · filed 2014-12-23 | ||
| 2012-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-09 | -$15.28K derived: sum of 2 quarters · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | -$65.02K derived: sum of 4 quarters · filed 2013-12-27 | ||
| 2012-03-31 | -$15.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-10 | $0.00 10-Q · filed 2013-05-10 | -$65.02K derived: sum of 3 quarters · filed 2013-12-27 | -$6.10K derived: sum of 4 quarters · filed 2013-12-27 | ||
| 2011-12-31 | $15.28K 10-Q · filed 2013-02-08 | -$49.74K derived: sum of 2 quarters · filed 2013-12-27 | $9.17K derived: sum of 3 quarters · filed 2013-12-27 | -$21.80K derived: sum of 4 quarters · filed 2013-12-27 | ||
| 2011-09-30 | -$65.02K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-27 | -$6.10K derived: sum of 2 quarters · filed 2013-12-27 | -$37.08K derived: sum of 3 quarters · filed 2013-12-27 | $28.53K 10-K · filed 2013-12-27 | ||
| 2011-06-30 | $58.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-09 | $27.95K derived: sum of 2 quarters · filed 2012-08-09 | $93.55K 10-Q · filed 2012-08-09 | |||
| 2011-03-31 | -$30.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-10 | $34.63K 10-Q · filed 2012-05-10 | ||||
| 2010-12-31 | $65.61K 10-Q · filed 2012-02-09 | |||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-09 | |||||
| 2009-09-30 | $7.29K 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |